Related Experiment Video
Updated: Jun 6, 2026
Primary Culture of Porcine Retinal Pigment Epithelial Cells
Published on: September 23, 2022
[Expressions and significances of PRL-3 and RhoC in A549 cell]
Ping ZHANG1, Zhipei ZHANG, Xiangmin LI
1Department of Thoracic Surgery, Tangdu Hospital, the Fourth Military Medical University, Xi'an 710038, China.
Background And Objective:
the expression of phosphatase of regenerating liver-3 (PRL-3) is correlated with Ras homologue C (RhoC) in non-small cell lung cancer (NSCLC), suggesting that they have interactions. The aim of this study is to investigate the functions of PRL-3 and RhoC in the migration of A549 cell and the potential mechanism of PRL-3 and RhoC in carcinogenesis and cancer development..
Methods:
PRL-3Ab and RhoCAb were used to block the functions of PRL-3 and RhoC respectively. Wound healing assay was applied to detect the migration of A549 cell and the expression levels of PRL-3 and RhoC were detected by RT-PCR.
Results:
the migration of A549 cell decreased after blockage of PRL-3 and RhoC. The expression of RhoC decreased when PRL-3 was blocked without any changes on the expression of PRL-3.
Conclusions:
PRL-3, RhoC could increase cell migration in A549 cells.
Insights
Phosphatase of regenerating liver-3 (PRL-3) and Ras homologue C (RhoC) promote non-small cell lung cancer cell migration. Blocking these proteins reduces A549 cell migration, indicating their role in cancer progression.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Phosphatase of regenerating liver-3 (PRL-3) expression correlates with Ras homologue C (RhoC) in non-small cell lung cancer (NSCLC).
- This suggests a potential interaction and functional relationship between PRL-3 and RhoC in NSCLC pathogenesis.
Purpose of the Study:
- To investigate the functional roles of PRL-3 and RhoC in the migration of A549 lung cancer cells.
- To elucidate the underlying molecular mechanisms of PRL-3 and RhoC in carcinogenesis and cancer development.
Main Methods:
- Utilized antibodies (PRL-3Ab, RhoCAb) to block the functions of PRL-3 and RhoC.
- Employed wound healing assays to assess A549 cell migration.
- Quantified PRL-3 and RhoC expression levels using RT-PCR.
Main Results:
- Inhibition of PRL-3 and RhoC significantly decreased A549 cell migration.
- Blocking PRL-3 led to a reduction in RhoC expression, while PRL-3 expression remained unchanged.
Conclusions:
- PRL-3 and RhoC play crucial roles in promoting cell migration in A549 non-small cell lung cancer cells.
- These findings highlight the potential of targeting PRL-3 and RhoC pathways in NSCLC treatment strategies.
